» Articles » PMID: 31586546

The Diversification of Cell Death and Immunity: Memento Mori

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2019 Oct 7
PMID 31586546
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Why do cells have so many ways to die? Why does "cellular suicide" exist at all? In the war against pathogens and rogue cells, organisms developed cellular suicide as a last resort. Fighting an evolutionary arms race, cell death pathways have adapted and multiplied to cover the complexity of the foes the immune system faces. In this review, we discuss the different types of cell death, the underlying signaling events, and their unequal ability to trigger an immune response. We also comment on how to use our knowledge of cell death signaling to improve the efficacy of cancer treatment. We argue that cell death is integral to the immune response and acts as a beacon, a second messenger, that guides both immune system and tissue micro-environment to ensure tissue repair and homeostasis. Memento mori-"remember you must die"-as failure to do so opens the way to chronic infection and cancer.

Citing Articles

A Targeted Nanotoxin Inhibits Colorectal Cancer Growth Through Local Tumor Pyroptosis and Eosinophil Infiltration and Degranulation.

Carrasco-Diaz L, Gallardo A, Volta-Duran E, Virgili A, Paez D, Villaverde A Int J Nanomedicine. 2025; 20:2445-2460.

PMID: 40034221 PMC: 11873025. DOI: 10.2147/IJN.S499192.


Attenuated growth factor signaling during cell death initiation sensitizes membranes towards peroxidation.

Gollowitzer A, Pein H, Rao Z, Waltl L, Bereuter L, Loeser K Nat Commun. 2025; 16(1):1774.

PMID: 40000627 PMC: 11861335. DOI: 10.1038/s41467-025-56711-2.


Identification of cuproptosis and ferroptosis-related subtypes and development of a prognostic signature in colon cancer.

He Y, Liu F, Li Q, Jiang Z PLoS One. 2025; 20(1):e0307013.

PMID: 39883700 PMC: 11781745. DOI: 10.1371/journal.pone.0307013.


Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumors.

Orehek S, Ramuta T, Lainscek D, Malensek S, Sala M, Bencina M Nat Commun. 2024; 15(1):10801.

PMID: 39737979 PMC: 11686184. DOI: 10.1038/s41467-024-55083-3.


How could histotripsy change cancer immunotherapy?.

Queen H, Cho C Immunotherapy. 2024; 17(1):1-3.

PMID: 39690949 PMC: 11834414. DOI: 10.1080/1750743X.2024.2442899.